Pulmonary Hypertension Study: The Prostacyclin Pathway

admin avatar

by admin |

Share this article:

Share article via email

Dr. Vallerie McLaughlin talks about the role of the prostacyclin pathway in pulmonary hypertension (PH). Dr. McLaughlin is a specialist in Cardiology and Internal Medicine at the University of Michigan Frankel Cardiovascular Center and was involved in GRIPHON, a large study of pulmonary hypertension that led to the approval of Selexipag, an oral drug for PH.

Keep updated on all the latest PH news here: http://bit.ly/20LXxHN